Our BioIVT Family
XenoTech was acquired by BioIVT in September of 2022. BioIVT, formerly BioreclamationIVT, is a leading global provider of high-quality biological specimens and value-added services. The partnering of BioIVT and XenoTech provides expanded offerings for ADME-Tox and Drug-Drug Interaction research services as well as a broadened array of research products. The acquisition also gives customers of XenoTech and BioIVT access to a larger team of highly experienced scientists and study directors in pharmacokinetics, metabolism, DDI, toxicology, and transporter research.
BioIVT specializes in control and disease state samples including human and animal tissues, cell products, blood, and other biofluids. Their unmatched portfolio of clinical specimens directly supports precision medicine research and the effort to improve patient outcomes by coupling comprehensive clinical data with donor samples. BioIVT’s leading hepatocyte portfolio combined with XenoTech’s strengths in subcellular products, including microsomes, will provide you with a more comprehensive offering of hepatic research models.
Our combined Research Services team works collaboratively with clients to help them better understand the pharmacokinetics and drug metabolism of compounds and their effects on disease processes. By combining our technical expertise, exceptional customer service, and unparalleled access to biological specimens, we can better serve the research community as a trusted partner in ELEVATING SCIENCE®.
Our History
Read more about our past history, partnership, growth, and how we work together to provide you with superior solutions to advance your drug’s development
Learn More About BioIVT
Find details about our partner and how your compound’s development can benefit from their expertise
